Form 4: Clene Director Sells $96K in Stock Under 10b5-1 Plan

Clene Inc. Director and 10% owner Chidozie Ugwumba sold 19,274 shares of common stock totaling approximately $96,040 over three days in late January 2026, pursuant to a Rule 10b5-1 plan.

Summary

• Chidozie Ugwumba, a Director and 10% owner of Clene Inc. (CLNN), reported sales of common stock.
• The transactions occurred on January 26, 27, and 28, 2026.
• A total of 19,274 shares were sold indirectly through Symbiosis II, LLC.
• The sales were executed at prices ranging from $4.91 to $5.08 per share.
• The total value of the shares sold was approximately $96,040.15.
• These transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
• Following these transactions, the indirect beneficial ownership through Symbiosis II, LLC stands at 580,329 shares.

Sentiment

Score: 3

Explanation: The sentiment is negative due to significant insider selling by a Director and 10% owner. Although executed under a 10b5-1 plan, such sales often signal a lack of confidence in the company's future prospects or valuation from a key insider's perspective.

Negatives

• A Director and 10% owner selling a significant number of shares (19,274 shares) may be interpreted by some investors as a less confident signal regarding the company's short-term prospects or valuation, even if pre-planned.
• The sales occurred over three consecutive days, indicating a deliberate reduction in exposure.

Risks

• Insider selling, even under a Rule 10b5-1 plan, can be interpreted by the market as a negative signal, potentially leading to downward pressure on the stock price.
• A reduction in ownership by a 10% owner might reduce alignment of interests with other shareholders over time.

Future Outlook

NA

Industry Context

This filing reports an individual insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• Chidozie Ugwumba's beneficial ownership and the reported transactions are indirect through Symbiosis II, LLC, indicating a related party relationship for these dealings.

Stakeholder Impact

• Shareholders may perceive the insider selling as a negative signal, potentially impacting investor confidence and the stock price.
• The reduction in ownership by a significant stakeholder could lead to questions about long-term commitment or future performance.

Key Dates

Recommendation

The sale of shares by a Director and 10% owner, Chidozie Ugwumba, totaling approximately $96,040, was executed pursuant to a pre-arranged Rule 10b5-1 trading plan. While such plans are designed to avoid accusations of trading on inside information, the act of a key insider reducing their stake can still be perceived by the market as a less confident signal regarding the company's future valuation or prospects. Investors should hold and monitor for further fundamental news, as these pre-scheduled sales may not reflect new negative information but rather a planned diversification or liquidity event.

Keywords

Clene Inc., CLNN, Insider Selling, Form 4, Director Sales, Stock Transaction, Beneficial Ownership, Chidozie Ugwumba, Symbiosis II LLC, 10b5-1 Plan